Predictors of first-line antiretroviral treatment failure among children on antiretroviral therapy at the University of Gondar comprehensive specialised hospital, North-west, Ethiopia: a 14-year long-term follow-up study
暂无分享,去创建一个
[1] Y. Kamiya,et al. Has the double burden of malnutrition reached pupils in rural western Kenya? , 2021, Pediatrics international : official journal of the Japan Pediatric Society.
[2] C. Macintyre,et al. Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China , 2020, BMC Infectious Diseases.
[3] A. D. Tilahun,et al. HIV positive status disclosure and associated factor among HIV infected children in pediatric ART clinics in Gondar town public health facilities, North West Ethiopia, 2018. , 2019, Journal of infection and public health.
[4] Young Ki Choi,et al. Rapid and simple colorimetric detection of multiple influenza viruses infecting humans using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform , 2019, BMC Infectious Diseases.
[5] Y. Assefa,et al. HIV-1 treatment failure among population taking Antiretroviral Therapy in Ethiopia , 2019 .
[6] P. Kaleebu,et al. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy–evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011 , 2018, The Pan African medical journal.
[7] K. Gelaye,et al. Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study , 2018, BMJ Open.
[8] F. Islahudin,et al. Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients , 2018, The open AIDS journal.
[9] G. A. Alemie,et al. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia , 2017, PloS one.
[10] B. T. Tadesse,et al. Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia , 2017, BMJ Open.
[11] G. B. Gebretekle,et al. Magnitude and predictors of antiretroviral treatment failure among HIV‐infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study , 2017, Pharmacology research & perspectives.
[12] S. Shankar,et al. Predictors of first line antiretroviral therapy failure and burden of second line antiretroviral therapy. , 2017, Medical journal, Armed Forces India.
[13] Abiyie Zeleke. Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University Hospital, retrospective cohort study , 2016 .
[14] Degefaye Zelalem Anlay,et al. Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study , 2016, AIDS Research and Therapy.
[15] A. Reepalu,et al. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic , 2016, Global health action.
[16] Dr. Maya Borle,et al. Opportunistic Infection among HIV Infected Children and Their CD 4 Cell Correlates , 2016 .
[17] L. Teixeira,et al. Work ability and associated factors of Brazilian technical-administrative workers in education , 2016, BMC Research Notes.
[18] K. Yirdaw,et al. Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia , 2015, PloS one.
[19] D. Gibb,et al. Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study. , 2015, The lancet. HIV.
[20] H. Helmby. Human helminth therapy to treat inflammatory disorders- where do we stand? , 2015, BMC Immunology.
[21] C. Giaquinto,et al. Predictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda. , 2015, Journal of the Pediatric Infectious Diseases Society.
[22] Crispin Moyo,et al. Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH): Facility-Level ART Unit Cost Analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia , 2014, PloS one.
[23] A. Ebonyi,et al. Nonadherence to first‑line antiretroviral therapy among human immunodeficiency virus‑1 infected children at the Jos University Teaching Hospital, Jos, Nigeria , 2014 .
[24] Yu-Jiun Chan,et al. Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan , 2014, BMC Infectious Diseases.
[25] Robert Sebunya,et al. Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic , 2013, AIDS Research and Therapy.
[26] R. Paranjape,et al. Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] K. L. Le Roch,et al. High content live cell imaging for the discovery of new antimalarial marine natural products , 2012, BMC Infectious Diseases.
[28] T. Applegate,et al. Multiple shRNA combinations for near-complete coverage of all HIV-1 strains , 2011, AIDS research and therapy.
[29] M. Hughes,et al. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy. , 2006, Archives of pediatrics & adolescent medicine.
[30] Philimon N. Gona,et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. , 2006, JAMA.
[31] S. Hugonnet,et al. Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. , 2006, The Journal of infectious diseases.